E M Yoshida

Summary

Affiliation: University of British Columbia
Country: Canada

Publications

  1. ncbi request reprint Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance?
    Alnoor Ramji
    Department of Medicine, University of British Columbia and the British Columbia Transplant Society, Vancouver, Canada
    Dig Dis Sci 47:522-7. 2002
  2. pmc Liver transplant candidacy unsuitability: a review of the British Columbia experience
    Jaber Alali
    Department of Medicine, University of British Columbia
    Can J Gastroenterol 20:95-9. 2006
  3. ncbi request reprint Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection
    Eric M Yoshida
    Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    Ann Hepatol 12:282-93. 2013
  4. pmc Cholestatic jaundice, acute kidney injury and acute pancreatitis secondary to the recreational use of methandrostenolone: a case report
    Greg A Rosenfeld
    Department of Medicine, University of British Columbia, 5th Floor, Gordon and Leslie Diamond Health Care Centre, 2775 Laurel St, Vancouver, BC, V5Z 1M9, Canada
    J Med Case Reports 5:138. 2011
  5. pmc Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy
    E M Yoshida
    University of British Columbia, Vancouver, Canada
    Can J Gastroenterol 23:180-4. 2009
  6. doi request reprint Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin
    V G Bain
    Department of Medicine, University of Alberta, Edmonton, AB, Canada
    Aliment Pharmacol Ther 28:43-50. 2008
  7. pmc Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3
    J Powis
    Department of Medicine, University of Toronto, Toronto, ON, Canada
    J Viral Hepat 15:52-7. 2008
  8. ncbi request reprint Recurrent ectopic pancreatitis of the jejunum and mesentery over a 30-year period
    John C T Wong
    Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    Hepatobiliary Pancreat Dis Int 10:218-20. 2011
  9. ncbi request reprint Failure of ketoprofen and interferon combination therapy to improve interferon-resistant chronic hepatitis C
    F H Anderson
    Department of Medicine, University of British Columbia, Vancouver
    Can J Gastroenterol 11:294-7. 1997
  10. ncbi request reprint Spatulated end-to-end bile duct reconstruction in orthotopic liver transplantation
    Andrzej K Buczkowski
    Department of Surgery, Section of Hepatobiliary, Pancreatic and Transplant Surgery, The University of British Columbia, The British Columbia Transplant Society, Vancouver, BC, Canada
    Clin Transplant 21:7-12. 2007

Collaborators

  • Vincent G Bain
  • M Sherman
  • M Krajden
  • S S Lee
  • Andrzej K Buczkowski
  • David F Schaeffer
  • R Balshaw
  • A Levin
  • C Cooper
  • E Jenny Heathcote
  • Marc Bilodeau
  • C S Wang
  • L A Forrester
  • J K Law
  • D S Krygier
  • S Zou
  • P J Marotta
  • W J Wall
  • Marcelo Cantarovich
  • Siegfried R Erb
  • Urs P Steinbrecher
  • Charles H Scudamore
  • Mazhar Haque
  • Stephen W Chung
  • Jin K Ho
  • Alnoor Ramji
  • Alison Harris
  • Hin Hin Ko
  • E H Z Wang
  • Greg A Rosenfeld
  • John C T Wong
  • Charlotte Robinson
  • Zamil Karim
  • Janakie Singham
  • Erica D Greanya
  • N Partovi
  • Pongphob Intaraprasong
  • J Powis
  • Elsie Cheung
  • John G Soos
  • P T Kim
  • I S H Cadden
  • Henry V Chung
  • R D Levy
  • Jin Kee Ho
  • Jaber Alali
  • James J Powell
  • Peter Ghali
  • Justin Cheung
  • Nilufar Partovi
  • U P Steinbrecher
  • Ahmad A AlDosary
  • E D Greanya
  • K A Northcott
  • R J Shapiro
  • S Gill
  • A L Stephenson
  • Albert Chang
  • Peter Kwan
  • Edward C Jones
  • Richard K Simons
  • Charles Zwirewich
  • Robert Wakefield
  • Michael Poulin
  • Almoutaz Hashim
  • Polly Cooper
  • Kirby Lau
  • David Owen
  • Nilu Partovi
  • Andrzej K Buzckowski
  • P Andrew Schumacher
  • Tim K Lee
  • M Deschenes
  • K M Peltekian
  • Erica Greanya
  • Benjamin Leung
  • J E Davis
  • S R Erb
  • Laura T Arbour
  • Richard Schreiber
  • Colin Barker
  • Mark Riley
  • Gareth P Jevon
  • Eileen M Brooks
  • Clare A Bannon
  • Wichian Apiratpracha
  • Theresa Mo
  • Bina Kopit
  • Christopher H Sherlock
  • Cherise Wong

Detail Information

Publications39

  1. ncbi request reprint Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance?
    Alnoor Ramji
    Department of Medicine, University of British Columbia and the British Columbia Transplant Society, Vancouver, Canada
    Dig Dis Sci 47:522-7. 2002
    ..Clearly, although a significant degree of allograft tolerance can occur, autoimmune diseases can still develop elsewhere, suggesting selective immune tolerance...
  2. pmc Liver transplant candidacy unsuitability: a review of the British Columbia experience
    Jaber Alali
    Department of Medicine, University of British Columbia
    Can J Gastroenterol 20:95-9. 2006
    ..Every centre has contraindications to liver transplantation and declares patients unsuitable for medical or nonmedical reasons. To date, there has been no published review of any centre's experience...
  3. ncbi request reprint Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection
    Eric M Yoshida
    Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    Ann Hepatol 12:282-93. 2013
    ..3%) compared to cyclosporine (18.7%) was also observed. Pre-transplant diabetes mellitus was associated with a significantly increased likelihood of graft fibrosis (HR 1.95, P = 0.003)...
  4. pmc Cholestatic jaundice, acute kidney injury and acute pancreatitis secondary to the recreational use of methandrostenolone: a case report
    Greg A Rosenfeld
    Department of Medicine, University of British Columbia, 5th Floor, Gordon and Leslie Diamond Health Care Centre, 2775 Laurel St, Vancouver, BC, V5Z 1M9, Canada
    J Med Case Reports 5:138. 2011
    ..abstract:..
  5. pmc Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy
    E M Yoshida
    University of British Columbia, Vancouver, Canada
    Can J Gastroenterol 23:180-4. 2009
    ..In contrast to the wealth of studies in treatment-naive patients, the effectiveness of retreatment in patients who have previously failed pegIFN-based therapy is largely unreported...
  6. doi request reprint Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin
    V G Bain
    Department of Medicine, University of Alberta, Edmonton, AB, Canada
    Aliment Pharmacol Ther 28:43-50. 2008
    ..The impact of reduced drug exposure on outcomes in patients with chronic hepatitis C has not been determined in routine clinical practice...
  7. pmc Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3
    J Powis
    Department of Medicine, University of Toronto, Toronto, ON, Canada
    J Viral Hepat 15:52-7. 2008
    ..027). There is significant interaction between cirrhosis and genotype 3 leading to a poor antiviral response in such patients requiring an alternate management strategy. This finding should be confirmed in a larger population...
  8. ncbi request reprint Recurrent ectopic pancreatitis of the jejunum and mesentery over a 30-year period
    John C T Wong
    Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    Hepatobiliary Pancreat Dis Int 10:218-20. 2011
    ....
  9. ncbi request reprint Failure of ketoprofen and interferon combination therapy to improve interferon-resistant chronic hepatitis C
    F H Anderson
    Department of Medicine, University of British Columbia, Vancouver
    Can J Gastroenterol 11:294-7. 1997
    ..These results provide no convincing evidence that the combination of IFN-alpha 2b with ketoprofen improves the response to IFN in patients nonresponsive to IFN alone...
  10. ncbi request reprint Spatulated end-to-end bile duct reconstruction in orthotopic liver transplantation
    Andrzej K Buczkowski
    Department of Surgery, Section of Hepatobiliary, Pancreatic and Transplant Surgery, The University of British Columbia, The British Columbia Transplant Society, Vancouver, BC, Canada
    Clin Transplant 21:7-12. 2007
    ..Despite the modest number of cases in this study this technique shows promise and has become the technique of choice in our institution...
  11. doi request reprint Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past
    E H Z Wang
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada
    Transpl Infect Dis 14:519-25. 2012
    ..Consequently, there is lack of standardization of prophylaxis duration (3 months to lifelong, depending on organ group) in SOT programs...
  12. ncbi request reprint Primary protein-losing enteropathy in anti-double-stranded DNA disease: the initial and sole clinical manifestation of occult systemic lupus erythematosus?
    K A Northcott
    Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada
    J Clin Gastroenterol 33:340-1. 2001
    ..A diagnosis of occult systemic lupus erythematosus resulting in increased intestinal vascular permeability was made. The hypoalbuminemia remained in long-term remission after the initiation of induction and maintenance immunosuppression...
  13. ncbi request reprint Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis
    C S Wang
    Department of Medicine and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada
    Am J Transplant 6:1586-99. 2006
    ..Clinical trials are needed to evaluate reasons for this post-transplant therapeutic disadvantage and to find strategies to ameliorate them...
  14. ncbi request reprint Obstacles to residents' conducting research and predictors of publication
    S Gill
    Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Acad Med 76:477. 2001
    ..Insufficient time was the key obstacle to completing research. Residents with previous research experience, senior residents, and men were more likely to publish...
  15. ncbi request reprint Impaired exercise performance after successful liver transplantation
    A L Stephenson
    Respiratory Division, Vancouver General Hospital, 2775 Heather Street, Vancouver, BC, Canada, V5Z 3J5
    Transplantation 72:1161-4. 2001
    ....
  16. ncbi request reprint A cross-sectional study of SEN virus in liver transplant recipients
    E M Yoshida
    Department of Medicine, University of British Columbia, British Columbia Transplant Society, Vancouver, BC
    Liver Transpl 7:521-5. 2001
    ..There is a suggestion that SEN V may be associated with HCV recurrence, but we did not detect biochemical differences attributable to SEN V...
  17. ncbi request reprint A case of recurrent pyogenic cholangitis
    D S Krygier
    Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Dig Liver Dis 40:386. 2008
  18. pmc Colonic malakoplakia in a liver transplant recipient
    P T Kim
    Department of Surgery, University of British Columbia, Vancouver, Canada
    Can J Gastroenterol 21:753-5. 2007
    ..The present case indicates that malakoplakia may be associated with chronic diarrhea, even if there are no macroscopic lesions seen during colonoscopy...
  19. ncbi request reprint Review article: possible beneficial effects of coffee on liver disease and function
    I S H Cadden
    Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Aliment Pharmacol Ther 26:1-8. 2007
    ..A number of investigators have focused their attention on the relationship between the consumption of coffee and liver disease...
  20. pmc All that bleeds is not infliximab-refractory ulcerative colitis
    J K Law
    Division of Gastroenterology, University of British Columbia, and Gastroenterology Clinic, St Paul s Hospital, Vancouver, British Columbia, Canada
    Can J Gastroenterol 23:91-2. 2009
    ..The patient was treated with infliximab and discharged with clinical remission, but subsequently presented back to hospital with a lower gastrointestinal hemorrhage...
  21. ncbi request reprint Post-liver transplantation diabetes mellitus: an association with hepatitis C
    Ahmad A AlDosary
    Division of Endocrinology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Liver Transpl 8:356-61. 2002
    ..12; 95% CI, 1.91 to 8.90) and de novo PTDM (OR, 6.02; 95% CI, 2.55 to 14.20). In conclusion, DM post-liver transplantation is a common occurrence and is associated with HCV...
  22. ncbi request reprint Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience
    Peter Ghali
    Department of Medicine, McGill University, Montreal, Quebec, Canada
    Liver Transpl 11:1412-6. 2005
    ..Aggressive investigation for cholangiocarcinoma is mandated. Incidentally found tumours remain a difficult treatment problem, and prospective adjuvant chemo-, radio-, and immunotherapies should be investigated...
  23. ncbi request reprint Remission of multiple sclerosis post-liver transplantation
    Eric M Yoshida
    Division of Neurology, The Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Can J Neurol Sci 31:539-41. 2004
    ..The effect of liver transplantation on pre-existing multiple sclerosis (MS) has never been reported. We report the three year post-transplant neurological outcome of a patient with MS...
  24. ncbi request reprint Comparison of acoustic radiation force impulse imaging (ARFI) to liver biopsy histologic scores in the evaluation of chronic liver disease: A pilot study
    Mazhar Haque
    Division of Gastroenterology, University of British Columbia, Canada
    Ann Hepatol 9:289-93. 2010
    ..The aim of this study is to investigate the feasibility of ARFI imaging as a non-invasive method for the assessment of liver fibrosis compared to liver biopsy scores...
  25. ncbi request reprint Management of polycystic liver disease
    Justin Cheung
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Can J Gastroenterol 18:666-70. 2004
    ..Currently, there are no guidelines for the management of PCLD patients and the optimal intervention is controversial. This article reviews the pathogenesis, classification and spectrum of treatment options for PCLD...
  26. ncbi request reprint Spontaneous clearance of hepatitis C infection post-liver transplant: A rare but real phenomenon? A case report and review of the literature
    Mazhar Haque
    University of British Columbia, Canada
    Ann Hepatol 9:202-6. 2010
    ..Better understanding of this phenomenon may help to manage recurrent HCV disease after transplantation...
  27. ncbi request reprint Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence
    Janakie Singham
    University of British Columbia, Vancouver BC, Canada
    Ann Hepatol 9:166-71. 2010
    ..This study examines the efficacy and patient preference of subcutaneous (SC) administration of HBIG in maintaining anti HBs titres > 100 IU/L...
  28. pmc Predictors of relapse to significant alcohol drinking after liver transplantation
    Zamil Karim
    Department of Medicine, University of British Columbia, Vancouver, British Columbia
    Can J Gastroenterol 24:245-50. 2010
    ..Alcohol relapse after LT can have detrimental outcomes such as graft loss and can contribute to a negative public perception of LT...
  29. ncbi request reprint Late acute rejection after liver transplantation: the Western Canada experience
    Alnoor Ramji
    Department of Medicine, The University of British Columbia, Vancouver, BC, Canada
    Liver Transpl 8:945-51. 2002
    ..LAR is common and occurs after more than 1 year posttransplantation. Patients undergoing transplantation for viral etiologies seem to have a lower risk of LAR. There may be an increased risk of chronic rejection in those developing LAR...
  30. ncbi request reprint Late acute celiac and hepatic artery thrombosis with portal vein thrombosis resulting in hepatic infarction 12 years post orthotopic liver transplantation
    Mazhar Haque
    Division of Gastroenterology, University of British Columbia, British Columbia Transplant Society, BC, Canda
    Ann Hepatol 8:396-9. 2009
    ..The acute presentation of sub massive hepatic necrosis is also uncharacteristic of late HAT and more typical of acute HAT. This report describes our experience in managing this and a literature review of the topic...
  31. pmc Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation
    Darin S Krygier
    Division of Gastroenterology, Department of Medicine, Vancouver General Hospital, Vancouver, BC V5Z 1M9, Canada
    World J Gastroenterol 15:4067-9. 2009
    ..This case suggests that Parvovirus B19 induced liver disease can affect adults, can occur in the absence of hematologic abnormalities and can be severe enough to require liver transplantation...
  32. ncbi request reprint Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinic
    Eric M Yoshida
    Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Liver Transpl 11:1064-72. 2005
    ..5 mL/min/1.73 m(2); P = 0.038). In conclusion, delayed low-dose tacrolimus, in combination with daclizumab and mycophenolate mofetil, preserves early renal function post-liver transplantation without the cost of increased acute rejection...
  33. ncbi request reprint Mycophenolate mofetil in liver transplant patients with calcineurin-inhibitor-induced renal impairment
    Hin Hin Ko
    Division of Gastroenterology, Gordon and Leslie Diamond Health Care Centre, Vancouver, BC, Canada
    Ann Hepatol 7:376-80. 2008
    ..In this study, we retrospectively investigated the efficacy and safety of mycophenolate mofetil (MMF) in OLTx patients with CNI-induced renal impairment...
  34. ncbi request reprint Utilization of a liver allograft from a hepatitis B surface antigen positive donor
    Jin Kee Ho
    Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    Transplantation 81:129-31. 2006
    ..Our experience suggests that with effective antiviral therapy, the use of HBsAg seropositive donors is feasible in selected circumstances...
  35. ncbi request reprint Post-liver transplantation immunosuppression: the song does not remain the same
    Eric M Yoshida
    Department of Medicine, University of British Columbia, Vancouver
    Can J Gastroenterol 16:65-6. 2002
  36. ncbi request reprint Sexual health after orthotopic liver transplantation
    Jin K Ho
    Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Liver Transpl 12:1478-84. 2006
    ....
  37. pmc Retrospective review of pediatric and adult autoimmune hepatitis in two quaternary care centres in British Columbia: increased prevalence seen in British Columbia's First Nations community
    Henry V Chung
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Can J Gastroenterol 21:565-8. 2007
    ..The researchers hypothesized that this community may also be at increased risk for autoimmune hepatitis (AIH)...
  38. ncbi request reprint Autoimmune liver disease and the Canadian First Nations Aboriginal Communities of British Columbia's Pacific Northwest
    Eric M Yoshida
    Department of Medicine, University of British Columbia, Vancouver, Canada
    World J Gastroenterol 12:3625-7. 2006
    ..Evidence suggesting that autoimmune hepatitis is also more likely amongst BC's First Nations communities is also presented...
  39. ncbi request reprint Subcutaneous administration of hepatitis B immune globulin in combination with lamivudine following orthotopic liver transplantation: effective prophylaxis against recurrence
    James J Powell
    Department of Surgery, University of British Columbia, British Columbia Transplant Society, Vancouver General Hospital, BC, Canada
    Clin Transplant 20:524-5. 2006
    ..Our experience suggests that subcutaneous delivery of HBIG may be a feasible consideration when intramuscular/intravenous dosing is not possible...